Drugs Under Development
- Elvitegravir (GS 9137 or JTK-303), licensed by Gilead Sciences from Japan Tobacco, is currently undergoing Phase 3 clinical trials. GS 9137 is a low-molecular-weight, highly selective integrase inhibitor that shares the core structure of quinolone antibiotics.
- MK-2048, a second generation integrase inhibitor, that appears to have a duration of action up to 4 times longer than raltegravir.
Read more about this topic: Integrase Inhibitor
Famous quotes containing the words drugs and/or development:
“Razors pain you;
Rivers are damp;
Acids stain you;
And drugs cause cramp.
Guns aren’t lawful;
Nooses give;
Gas smells awful;
You might as well live.”
—Dorothy Parker (1893–1967)
“Men are only as good as their technical development allows them to be.”
—George Orwell (1903–1950)